Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Mary's Medicinals is stocked at 749 licensed dispensaries across California, Michigan, and 9 other states, 286 of them in California, with the deepest coverage in Los Angeles, Sacramento, San Diego, La Mesa, and Vista. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Mary's Medicinals derived 73.68% of sales from Topical, down 2.35% month over month and down 7.96% year over year, while Tincture & Sublingual expanded to 26.32% share with a 1.51% MoM lift and a 51.70% YoY increase. The brand’s overall sales were up 2.54% year over year despite a 34.07% decline over 24 months, and the average price rose 9.79% to $29.04, indicating mix and pricing tailwinds offsetting Topical contraction. The pattern implies a pivot where accelerating Tincture & Sublingual growth is increasingly compensating for softening Topical volumes, shifting the center of gravity within the portfolio.
With Topical still leading but receding (−2.35% MoM and −7.96% YoY) against a rising Tincture & Sublingual line (+1.51% MoM and +51.70% YoY), the brand’s category exposure is tilting toward formats that support price increases and share resilience. Holding the number 1 rank in Topical in Missouri while Topical mix shrinks to 73.68% suggests headroom to defend leadership locally even as national portfolio balance changes, pointing to a strategy that leverages anchor-category credibility to seed faster-growth sublinguals.
Competitive Landscape
Mary's Medicinals holds rank #2 in California Topical for October 2026, unchanged from #2 in October 2025, while its 3-month position also stayed at #2, implying a steady share relative to a static leaderboard where peak rank equaled #2 in October 2026; meanwhile, Papa & Barkley maintained #1 year over year as its sales declined 13.4%, and Liquid Flower advanced from #6 to #4 with a 17.9% sales increase, indicating competitive pressure from below despite the leader’s contraction. This pattern implies Mary's Medicinals is locked in a stable #2 slot that could become vulnerable if upward-trending challengers convert sales growth into rank gains while the category leader weakens.
Notable Products
Mary's Medicinals is concentrated in Topical formats, with Lotion, Salves, Gels, and Creams accounting for 55.8% of October 2026 sales and the top 10 items together making up 63.6%. The leading product, CBD/THC 1:1 Large Colling Action Relief Muscle Freeze (3oz), alone holds 9.1% share, so most of its sales come from a handful of cream-based topicals.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






